Advertisement
UK markets open in 52 minutes

  • NIKKEI 225

    38,768.41
    +532.34 (+1.39%)
     

  • HANG SENG

    18,509.27
    -69.03 (-0.37%)
     

  • CRUDE OIL

    78.69
    +0.21 (+0.27%)
     

  • GOLD FUTURES

    2,329.80
    -1.40 (-0.06%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • Bitcoin GBP

    50,700.10
    -470.62 (-0.92%)
     

  • CMC Crypto 200

    1,366.40
    +1.28 (+0.09%)
     

  • NASDAQ Composite

    16,349.25
    +192.92 (+1.19%)
     

  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     

Lonza concludes peptides business sale, books charges

Reuters - UK Focus

ZURICH, Jan 4 (Reuters) - Lonza has concluded the divestment of its peptides business in Belgium to PolyPeptide Laboratories Holding, the Swiss group said on Wednesday. It gave no financial terms.

"As announced (in) early December, Lonza has booked a non-cash related write-off of 44 million Swiss francs ($42.8 million). Furthermore, Lonza will also book a 29 million franc non-cash currency translation impact in the first half of 2017," it said.

($1 = 1.0279 Swiss francs) (Reporting by Michael Shields, editing by John Revill)